Clinical Trial Update: A Therapeutic Open Label Study of Tocilizumab in the Treatment of Pulmonary Arterial Hypertension [Phase 2]

View source ↗

Summary

Open-label Phase 2 trial evaluating tocilizumab for pulmonary arterial hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Actemra (tocilizumab)

Snippet

Sponsor: Papworth Hospital NHS Foundation Trust | Conditions: Pulmonary Arterial Hypertension | Phase 2 | Status: COMPLETED